Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02314546 · ClinicalTrials.gov registry record · Phase 4
Intranasal Midazolam in Children as a Pre-Operative Sedative
A Phase 4 study, sponsored by Bassett Healthcare.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT02314546: Completed Phase 4 study, sponsored by Bassett Healthcare.
NCT02314546 is a Phase 4 study that has completed, run by Bassett Healthcare. The registered enrollment target is 15 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02314546, a Phase 4 study, has completed, sponsored by Bassett Healthcare.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to see if adding a numbing medicine, xylocaine, to the nasal midazolam makes giving the midazolam easier and more comfortable without affecting how the midazolam works as a sedative.
Primary Outcome
Measured by the administering RN. Measured as: agitated, alert, calm, drowsy, asleep.
Interventions
- DRUG Midazolam
- DRUG saline placebo
- DRUG xylocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-01 |
| Phase | Phase 4 |
What the finished NCT02314546 record still lists
NCT02314546 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Midazolam is the first listed.
NCT02314546 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02314546 about?
NCT02314546 is a clinical study titled "Intranasal Midazolam in Children as a Pre-Operative Sedative". The purpose of this study is to see if adding a numbing medicine, xylocaine, to the nasal midazolam makes giving the midazolam easier and more comfortable without affecting how the midazolam works as a sedative.
What is the current status of trial NCT02314546?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2011-12. Estimated completion is 2014-01.
What interventions are being tested in trial NCT02314546?
The interventions under investigation include: Midazolam (DRUG), saline placebo (DRUG), xylocaine (DRUG).
Who is sponsoring clinical trial NCT02314546?
This trial is sponsored by Bassett Healthcare, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02314546's enrollment target sits among peer trials
15 1880th of 2000 higher than 100 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia